- Home
- JFR vs BLFS Comparison
JFR vs BLFS Comparison
Compare JFR & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JFR
- BLFS
- Stock Information
- Founded
- JFR 2004
- BLFS 1987
- Country
- JFR United States
- BLFS United States
- Employees
- JFR N/A
- BLFS N/A
- Industry
- JFR Trusts Except Educational Religious and Charitable
- BLFS Medical/Dental Instruments
- Sector
- JFR Finance
- BLFS Health Care
- Exchange
- JFR Nasdaq
- BLFS Nasdaq
- Market Cap
- JFR 1.1B
- BLFS 995.2M
- IPO Year
- JFR N/A
- BLFS 1989
- Fundamental
- Price
- JFR $8.53
- BLFS $22.68
- Analyst Decision
- JFR
- BLFS Strong Buy
- Analyst Count
- JFR 0
- BLFS 7
- Target Price
- JFR N/A
- BLFS $30.86
- AVG Volume (30 Days)
- JFR 621.7K
- BLFS 424.1K
- Earning Date
- JFR 01-01-0001
- BLFS 08-07-2025
- Dividend Yield
- JFR 11.31%
- BLFS N/A
- EPS Growth
- JFR N/A
- BLFS N/A
- EPS
- JFR N/A
- BLFS N/A
- Revenue
- JFR N/A
- BLFS $93,468,000.00
- Revenue This Year
- JFR N/A
- BLFS $21.22
- Revenue Next Year
- JFR N/A
- BLFS $17.50
- P/E Ratio
- JFR N/A
- BLFS N/A
- Revenue Growth
- JFR N/A
- BLFS 45.60
- 52 Week Low
- JFR $7.61
- BLFS $19.10
- 52 Week High
- JFR $8.82
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- JFR 59.83
- BLFS 57.68
- Support Level
- JFR $8.47
- BLFS $20.23
- Resistance Level
- JFR $8.53
- BLFS $21.31
- Average True Range (ATR)
- JFR 0.04
- BLFS 1.00
- MACD
- JFR -0.00
- BLFS 0.03
- Stochastic Oscillator
- JFR 90.00
- BLFS 65.97
About JFR Nuveen Floating Rate Income Fund
Nuveen Floating Rate Income Fund is a diversified closed-end management investment company. Its investment objective is to achieve a high level of current income, consistent with the preservation of capital. It invests in adjustable-rate U.S. dollar-denominated secured Senior Loans.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.